 |
 |

Biologic Fate of Human Arterial Homografts
D. EMERICK SZILAGYI, M.D.;
RICHARD T. McDONALD, M.D.;
ROGER F. SMITH, M.D.;
JOHN G. WHITCOMB, M.D.
AMA Arch Surg. 1957;75(4):506-529.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
In our experience—and insofar as the record shows, in the experience of others as well—the results of surgical procedures utilizing homologous arterial grafts in the surgical management of aneurysmal and occlusive arterial disease deteriorate as the postoperative follow-up period lengthens. The worsening of the results is not uniform in all anatomical areas and in all forms and degrees of disease. After four years' experience, from the point of view of technical excellence alone, the results of operations for aortic lesions appear best, although the long-term survival rate of patients with these lesions is unfavorably affected by the intercurrent manifestations of arteriosclerosis, mainly coronary thrombosis. Late deterioration of the results is commonest in patients with femoral and, especially, popliteal obliteration, a fact particularly disquieting, since this group of patients is the most numerous and generally has the best survival outlook. As a recent study1 shows, the commonest factor in the
. . . [Full Text PDF of this Article]
Author Affiliations
Detroit
From the Department of Surgery, Henry Ford Hospital.
Footnotes
Submitted for publication March 4, 1957.
Read before the 14th Annual Meeting of the Central Surgical Association, Chicago, Feb. 22, 1957.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|